Myocardial energetics: Still only the tip of an Iceberg

Heart Lung and Circulation

Volumn 12, Issue 1, 2003, Pages 3-6

  Taegtmeyer, Heinrich ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE TRANSPORTER 1;

ADAPTATION; DIAGNOSTIC PROCEDURE; EDITORIAL; ENERGY CONSUMPTION; ENERGY METABOLISM; ENERGY TRANSFER; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEART FAILURE; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART WORK; METABOLIC REGULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUTRIENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0042090645     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1444-2892.2003.00193.x     Document Type: Editorial

References (38)

1. Krebs HA, Martin A. Hans Krebs: Reminiscences and Reflections. Clarendon Press, Oxford, 1981.
2. Neely JR, Liebermeister H, Battersby EJ, Morgan HE. Effect of pressure development on oxygen consumption by isolated rat heart. Am. J. Physiol. 1967; 212: 804-14.
3. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy providing substrates in the isolated working rat heart. Biochem. J. 1980; 186: 701-11.
4. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J. Biol. Chem. 1998; 273: 29530-39.
5. Balaban RS. Cardiac energy metabolism homeostasis: role of cytosolic calcium. J. Mol. Cell Cardiol. 2002; 34: 1259-71.
6. Srere P. Citric acid cycle redux. TIBS 1990; 15: 411-12.
7. Taegtmeyer H, Dietze GJ. A symposium: From increased energy metabolism to cardiac hypertrophy and failure: Mediators and molecular mechanisms. Am. J. Cardiol. 1999; 83: 1H-98H.
8. Barger PM, Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc. Med. 2000; 10: 238-45.
9. Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, Taegtmeyer H. Metabolic gene expression in fetal and failing human heart. Circulation 2001; 104: 2923-31.
10. Lipmann F. Metabolic generation and utilization of phosphate bond energy. Adv. Enzymol. 1941; 1: 99-165.
11. Taegtmeyer H. Energy metabolism of the heart: From basic concepts to clinical applications. Curr. Prob. Cardiol. 1994; 19: 57-116.
12. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-9.
13. Baldwin JE, Krebs HA. The evolution of metabolic cycles. Nature 1981; 291: 381-2.
14. Taegtmeyer H, Passmore JM. Defective energy metabolism of the heart in diabetes. Lancet 1985; 1: 139-41.
15. Taegtmeyer H. Is there a rationale for glucose-insulin-potassium therapy in acute myocardial infarction? Cardiol. Rev. 1995; 3: 307-13.
16. Russell RR, Taegtmeyer H. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing aceto-acetate. Am. J. Physiol. 1991; 261: H1756-62.
17. Bradamante S, Marchesani A, Barenghi L, Paracchini L, de Jonge R, de Jonge J. Glycogen turnover and anaplerosis in preconditioned rat hearts. Biochim. Biophys. Acta 2000; 1502: 363-79.
18. Fell D. Understanding the Control of Metabolism. Portland Press, Miami, 1997.
19. Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. III. The steady state. J. Biol. Chem. 1955; 217: 409-27.
20. Cooney GJ, Taegtmeyer H, Newsholme EA. Tricarboxylic acid cycle flux and enzyme activities in the isolated working rat heart. Biochem. J. 1981; 200: 701-3.
21. Abel ED, Kaulbach HC, Tian R et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J. Clin. Invest. 1999; 104: 1703-14.
22. Liao R, Mohit J, Lei C et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure due to pressure-overload in mice. Circulation 2002; 106: 2125-31.
23. Finck BN, Lehman JJ, Leone TC et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 2002; 109: 121-30.
24. Liang Q, Donthi R., Kralik P, Epstein P. Elevated hexokinase increases cardiac glycolysis in transgenic mice. Cardiovasc. Res. 2002; 53: 423-30.
25. Taegtmeyer H. Switching metabolic genes to build a better heart. Circulation 2002; 106: 2043-5.
26. Belke DD, Betuing S, Tuttle MJ et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Invest. 2002; 109: 629-39.
27. Matsui T, Li L, Wu J et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 2002; 277: 22896-901.
28. Young ME, Guthrie P, Stepkowski S, Taegtmeyer H. Glucose regulation of sarcomeric protein gene expression in the rat heart. J. Molec. Cell Cardiol. 2001; A181.
29. van Bilsen M, Van der Vusse GJ, Reneman RS. Transcriptional regulation of metabolic processes: implications for cardiac metabolism. Pflugers Arch. 1998; 437: 2-14.
30. Xia Y, Wen HY, Young ME, Guthrie PH, Taegtmeyer H, Kellems RE. Mammalian target of rapamycin and protein kinase a signaling mediate the cardiac transcriptional response to glutamine. J. Biol. Chem 2003; 278: 13 143-50.
31. Kelly DP. Peroxisome proliferator-activated receptor alpha as a genetic determinant of cardiac hypertrophic growth: Culprit or innocent bystander? Circulation 2002; 105: 1025-7.
32. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am. J. Physiol. Heart Circ. Physiol. 2000; 278: H1345-51.
33. Young ME, Laws FA, Goodwin GW, Taegtmeyer H. Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J. Biol. Chem. 2001; 276: 44390-95.
34. Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 2002; 105: 1861-70.
35. Razeghi P, Young ME, Ying J et al. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 2002; 97: 203-9.
36. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996; 94: 2837-42.
37. Osorio J, Stanley W, Linke A et al. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 2002; 106: 606-12.
38. Davila-Roman VG, Vedala G, Herrero P et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 2002; 40: 271-7.